Novel treatment approach to combat an infection with Acinetobacter
- PMID: 20157502
- PMCID: PMC2804493
- DOI: 10.1080/08998280.2010.11928578
Novel treatment approach to combat an infection with Acinetobacter
Abstract
The antimicrobial resistance of gram-negative pathogens has become problematic. In some cases related to Pseudomonas spp. and Acinetobacter spp., no antimicrobials on the market can be utilized at standard doses. We report a case of resistant Acinetobacter infection in a patient in the intensive care unit. In this scenario, we successfully treated the infection with doripenem at a higher dose of 1 g with a 4-hour infusion time along with the combination of tigecycline and colistin.
Similar articles
-
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124. Ann Lab Med. 2016. PMID: 26709259 Free PMC article.
-
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.Clin Ther. 2016 Sep;38(9):2098-105. doi: 10.1016/j.clinthera.2016.07.172. Epub 2016 Sep 6. Clin Ther. 2016. PMID: 27612610
-
Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.Microb Pathog. 2021 Jan;150:104700. doi: 10.1016/j.micpath.2020.104700. Epub 2020 Dec 17. Microb Pathog. 2021. PMID: 33346078
-
Emerging infections in burns.Surg Infect (Larchmt). 2009 Oct;10(5):389-97. doi: 10.1089/sur.2009.024. Surg Infect (Larchmt). 2009. PMID: 19810827 Free PMC article. Review.
-
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.Int J Antimicrob Agents. 2009 Jul;34(1):8.e1-9. doi: 10.1016/j.ijantimicag.2008.11.006. Epub 2009 Jan 21. Int J Antimicrob Agents. 2009. PMID: 19162449 Review.
References
-
- Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–1281. - PubMed
-
- Murray CK, Hospenthal DR. Acinetobacter infection in the ICU. Crit Care Clin. 2008;24(2):237–248. - PubMed
-
- Talbot GH, Bradley J, Edwards JE, Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42(5):657–668. - PubMed
-
- Gilad J, Carmeli Y. Treatment options for multidrug-resistant Acinetobacter species. Drugs. 2008;68(2):165–189. - PubMed
-
- Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8(12):751–762. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous